Market Overview

Why Titan Pharmaceuticals Stock Is Trading Higher Today


Titan Pharmaceuticals (NASDAQ: TTNP) shares are trading higher on Wednesday after the company announced a deal to buy JT Pharma Kappa Opioid with a gross proceeds of at least $8 million.

Titan Pharmaceuticals is a specialty pharmaceutical company. It is engaged in the development and commercialization of pharmaceutical products. The company product pipeline consists of Probuphine for Opioid addiction, Ropinirole for Parkinson's disease, Triiodothyronine (T3) for hypothyroidism. It generates revenue principally from collaborative research and development arrangements, technology licenses, and government grants.

Titan Pharmaceuticals shares traded up 29.88% to 17 cents on Wednesday. The stock has a 52-week high of 54 cents and a 52-week low of 11 cents.


Related Articles (TTNP)

View Comments and Join the Discussion!

Posted-In: M&A News Penny Stocks

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at